Company Filing History:
2 out of 514 
2 out of 277 
Years Active: 2020-2024
Title: Innovations by Leonid Fomin in Automated Tissue Dissection
Introduction
Leonid Fomin is an accomplished inventor based in Santa Clara, CA (US). He has made significant contributions to the field of automated tissue dissection, holding 2 patents that enhance the precision and efficiency of biological specimen analysis.
Latest Patents
Fomin's latest patent is titled "Automated tissue dissection instrument and methods of using the same." This innovative system includes an instrument, a computer-implemented method, and a clinical workflow designed for mesodissection of biological specimens on tissue slides. The process involves acquiring an image of an annotated reference slide and transposing it onto multiple serial samples on the tissue slides, along with the corresponding annotations and metadata. The serial samples are milled based on these annotations, and the milled tissue is automatically collected with a milling buffer solution inside milling tips, which are then dispensed into designated collection vials. The instrument automates the filling of aqueous buffer inside the milling tips and monitors the buffer solution, ensuring a seamless workflow. This integrated interface performs tissue annotation, alignment, dissection, tracking, and reporting on a single screen. The degree of precision, ease of use, and repeatability provided by this invention will significantly improve PCR and NGS test results, ultimately delivering timely patient outcomes.
Career Highlights
Throughout his career, Leonid Fomin has worked with notable companies such as Ventana Medical Systems, Inc. and Roche Sequencing Solutions, Inc. His experience in these organizations has contributed to his expertise in the field of tissue dissection and analysis.
Collaborations
Fomin has collaborated with esteemed colleagues, including Nils B Adey and Dale B Emery, further enhancing the impact of his work in the industry.
Conclusion
Leonid Fomin's innovations in automated tissue dissection instruments represent a significant advancement in the field of biological specimen analysis. His contributions are poised to improve diagnostic processes and patient care outcomes.